Image for illustrative purposes only. Not a real photo.

Amplia and ANZGOG launch new ovarian cancer trial

Written by Heidi Cuthbert Published May 8, 2026, 12:30 AMLast Updated Jul 6, 2026, 10:28 AM

Amplia Therapeutics (ASX:ATX) has partnered with the Australia New Zealand Gynaecological Oncology Group to launch a new clinical trial targeting ovarian cancer.

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks Browse all ASX ETFs Explore Australia companies Find the right ASX index

More ways to discover

Assets related to this article